logo

Catabasis Pharmaceuticals, Inc. (CATB)



Trade CATB now with
  Date
  Headline
9/8/2021 8:18:18 AM Catabasis Pharmaceuticals Changes Name To Astria Therapeutics, Inc
1/29/2021 8:04:26 AM Catabasis Acquires Quellis Biosciences
7/29/2019 7:20:36 AM Wedbush Reiterates Catabasis Pharmaceuticals, Inc. (CATB) At Outperform With $18 Price Target
6/24/2019 10:03:28 AM Wedbush Reiterates Catabasis Pharmaceuticals, Inc. (CATB) At Outperform With $18 Price Target
3/20/2018 6:27:28 AM Wedbush Is Increasing Catabasis Pharmaceuticals, Inc. (CATB) FY18 Estimate To -0.91 From -1.00
3/20/2018 6:27:11 AM Wedbush Is Raising Catabasis Pharmaceuticals, Inc. (CATB) Q4 18 Estimate To -0.22 From -0.27
3/20/2018 6:27:01 AM Wedbush Is Raising Catabasis Pharmaceuticals, Inc. (CATB) Q3 18 Estimate To -0.23 From -0.27
3/20/2018 6:26:34 AM Wedbush Is Increasing Catabasis Pharmaceuticals, Inc. (CATB) Q1 18 Estimate To -0.23 From -0.24
3/20/2018 6:23:47 AM Wedbush Reiterates Catabasis Pharmaceuticals, Inc. (CATB) At Outperform With $6 Up From $5 Price Target
2/14/2018 8:05:02 AM Wedbush Reiterates Catabasis Pharmaceuticals, Inc. (CATB) At Outperform With $5 Up From $4 Price Target
12/15/2017 5:01:47 PM Wedbush Is Raising Catabasis Pharmaceuticals, Inc. (CATB) FY18 Estimate To -1.00 From -1.21
12/15/2017 5:01:25 PM Wedbush Is Raising Catabasis Pharmaceuticals, Inc. (CATB) Q4 18 Estimate To -0.27 From -0.32
12/15/2017 5:01:12 PM Wedbush Is Increasing Catabasis Pharmaceuticals, Inc. (CATB) Q3 18 Estimate To -0.27 From -0.32
12/15/2017 5:00:50 PM Wedbush Is Increasing Catabasis Pharmaceuticals, Inc. (CATB) Q2 18 Estimate To -0.23 From -0.31
12/15/2017 5:00:27 PM Wedbush Is Increasing Catabasis Pharmaceuticals, Inc. (CATB) Q1 18 Estimate To -0.24 From -0.26
12/15/2017 4:59:59 PM Wedbush Is Raising Catabasis Pharmaceuticals, Inc. (CATB) FY17 Estimate To -1.29 From -1.35
12/15/2017 4:59:41 PM Wedbush Is Increasing Catabasis Pharmaceuticals, Inc. (CATB) Q4 17 Estimate To -0.26 From -0.32
12/15/2017 4:59:14 PM Wedbush Reiterates Catabasis Pharmaceuticals, Inc. (CATB) At Outperform With $4 Price Target
10/4/2017 3:51:56 PM Wedbush Reiterates Catabasis Pharmaceuticals, Inc. (CATB) At Outperform With $4 Price Target